Vas Lakshmi Champak, Pai Renuka, Pattnaik Manorama
Ashirvad Institute for Pain Management and Research, Mumbai, India.
Pain Physician. 2016 Jan;19(1):E163-79.
Motor impairment is an important criterion in the Clinical Diagnostic Criteria (CDC) of Complex Regional Pain Syndrome type-1 (CRPS-1) as defined by International Association for Study of Pain (IASP).
To describe the changes in musculoskeletal ultrasonography (MSKUSG) in CRPS-1 before and after treatment with ultrasound-guided dry needling (USGDN) in retrospective data from 44 patients.
Patients irrespective of age, gender, or cause of CRPS were included in this retrospective data analysis; the Budapest criteria for the diagnosis of CRPS were stringently adhered to.
The analysis was done at Ashirvad Institute for Pain Management and Research with the database of CRPS patients who were treated between December 2005 and December 2014.
The CDC, range of motion at upper extremity joints, dynamometry, Disability of arm, shoulder and hand score (DASH) and ultrasonography were documented on days one, 15, and 45. MSKUSG demonstrated loss of myoarchitecture and reduced bulk.
All 44 patients received USGDN as the sole intervention with medications and physiotherapy. MSKUSG at 15 and 45 days after starting USGDN showed a return of normalcy to the myoarchitecture and muscle bulk increase that coincided with the disappearance of CDC and a progressive and predictable improvement of the DASH scores in all the 44 patients.
The analysis focuses on only 2 parameters: the musculoskeletal changes of the forearm flexors and extensors on ultrasound guidance and the efficacy of the dry needling treatment. It is not a comparative study with another accepted form of treatment or intervention. We have not looked into the age and gender predilection of the condition owing to the small sample size of the study. Analysis of long term maintenance of relief and rehabilitation of the disability were limited to one year.
Myofascial pathology of co-contraction appears to cause CDC of CRPS and probable ischemic loss of myoarchitecture. Relief of co-contraction with USGDN allowed resolution of tenosynovitis causing the CDC and return of normal myoarchitecture.
运动功能障碍是国际疼痛研究协会(IASP)定义的1型复杂性区域疼痛综合征(CRPS-1)临床诊断标准(CDC)中的一项重要标准。
通过对44例患者的回顾性数据,描述超声引导下干针疗法(USGDN)治疗前后CRPS-1患者肌肉骨骼超声检查(MSKUSG)的变化。
本回顾性数据分析纳入了无论年龄、性别或CRPS病因的患者;严格遵循布达佩斯CRPS诊断标准。
分析在阿希尔瓦德疼痛管理与研究机构进行,使用2005年12月至2014年12月期间接受治疗的CRPS患者数据库。
在第1天、第15天和第45天记录CDC、上肢关节活动范围、握力、手臂、肩部和手部功能障碍评分(DASH)以及超声检查结果。MSKUSG显示肌结构丧失和体积减小。
所有44例患者均接受USGDN作为唯一的干预措施,并辅以药物和物理治疗。开始USGDN治疗后第15天和第45天的MSKUSG显示肌结构恢复正常,肌肉体积增加,这与所有44例患者CDC的消失以及DASH评分的逐步且可预测的改善相吻合。
该分析仅关注两个参数:超声引导下前臂屈肌和伸肌的肌肉骨骼变化以及干针治疗的疗效。这不是与另一种公认的治疗或干预形式的对比研究。由于研究样本量小,我们未研究该疾病的年龄和性别偏好。对缓解的长期维持和残疾康复的分析仅限于一年。
协同收缩的肌筋膜病理似乎导致CRPS的CDC以及可能的肌结构缺血性丧失。USGDN缓解协同收缩可使导致CDC的腱鞘炎得到缓解,并使肌结构恢复正常。